Publications by authors named "Isabelle Rouquette"

Claim this Profile
U
Usefulness of an RNA extraction-free test for the multiplexed detection of , , and Gene Fusions in Real Life FFPE Specimens of Non-Small Cell Lung Cancers.
Francesca Damiola, Laurent Alberti, Audrey Mansuet-Lupo, Diane Damotte, Véronique Hofman, Isabelle Rouquette

Expert Rev Mol Diagn· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Lise Mangiante, Nicolas Alcala, Alexandra Sexton-Oates, Alex Di Genova, Abel Gonzalez-Perez, Isabelle Rouquette

Nat Genet· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC study.
Vincent Thomas de Montpreville, Audrey Mansuet-Lupo, Cécile Le Naoures, Lara Chalabreysse, Anne De Muret, Isabelle Rouquette

Virchows Arch· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Thymoma and squamous thymic carcinoma diagnosis; experience from the RYTHMIC network].
Lara Chalabreysse, Romain Dubois, Véronique Hofman, Cécile Le Naoures, Audrey Mansuet-Lupo, Isabelle Rouquette

Ann Pathol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.
Matthieu Dietz, Gilles Chironi, Yann-Erick Claessens, Ryan Lukas Farhad, Isabelle Rouquette

Eur J Nucl Med Mol Imaging· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study.
Thierry J Molina, Maria V Bluthgen, Lara Chalabreysse, Vincent T de Montpréville, Anne de Muret, Isabelle Rouquette

Eur J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by Mutation Subtypes.
Anne-Marie Ruppert, Michèle Beau-Faller, Didier Debieuvre, L'Houcine Ouafik, Virginie Westeel, Isabelle Rouquette

JTO Clin Res Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France Study.
Samuel Kembou Nzale, William B Weeks, L'Houcine Ouafik, Isabelle Rouquette, Michèle Beau-Faller

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial.
Julien Mazieres, Fabrice Barlesi, Isabelle Rouquette, Olivier Molinier, Benjamin Besse

Clin Cancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center.
Francoise Galateau Salle, Nolwenn Le Stang, Franck Tirode, Pierre Courtiol, Andrew G Nicholson, Isabelle Rouquette

J Thorac Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Use of combined cardiac and lung ultrasound to predict weaning failure in elderly, high-risk cardiac patients: a pilot study.
Belaid Bouhemad, Francesco Mojoli, Nicolas Nowobilski, Arif Hussain, Isabelle Rouquette

Intensive Care Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of combined cardiac and lung ultrasound to predict weaning failure in elderly, high-risk cardiac patients: a pilot study.
Belaid Bouhemad, Francesco Mojoli, Nicolas Nowobilski, Arif Hussain, Isabelle Rouquette

Intensive Care Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the QR1 Antibody for the Evaluation of PD-L1 Expression in Non-Small Cell Lung Adenocarcinomas.
Nicolas Brandone, Céline Mascaux, Kevin Caselles, Isabelle Rouquette, Sylvie Lantuejoul

Appl Immunohistochem Mol Morphol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Guidelines for the macroscopic management of surgically resected lung carcinoma].
Audrey Mansuet-Lupo, Marc Filaire, Philippe Chaffanjon, Marco Alifano, Fabien Forest, Isabelle Rouquette

Ann Pathol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1.
Isabelle Rouquette, Estelle Taranchon-Clermont, Julia Gilhodes, Maria-Virginia Bluthgen, Romain Perallon

Biomark Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Solène M Evrard, Estelle Taranchon-Clermont, Isabelle Rouquette, Samuel Murray, Sebastian Dintner

J Mol Diagn· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
Nicolas Guibert, Greg Jones, John F Beeler, Vincent Plagnol, Clive Morris, Isabelle Rouquette

Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions.
Nicolas Alcala, Lise Mangiante, Nolwenn Le-Stang, Corinne E Gustafson, Sandrine Boyault, Isabelle Rouquette

EBioMedicine· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
Solenn Brosseau, Claire Danel, Arnaud Scherpereel, Julien Mazières, Sylvie Lantuejoul, Isabelle Rouquette

Clin Lung Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-sensitive Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring Mutations and Treated with First-generation TKIs.
Julie A Vendrell, Julien Mazieres, Romain Senal, Isabelle Rouquette, Xavier Quantin

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.
Véronique Hofman, Isabelle Rouquette, Elodie Long-Mira, Nicolas Piton, Emmanuel Chamorey

J Thorac Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic p27 promotes tumorigenesis via suppression of RhoB activity.
Olivier Calvayrac, Ada Nowosad, Stéphanie Cabantous, Lin-Po Lin, Sarah Figarol, Isabelle Rouquette

J Pathol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas.
Xavier Mignard, Anne-Marie Ruppert, Martine Antoine, Julie Vasseur, Nicolas Girard, Isabelle Rouquette

J Thorac Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.
Nicolas Guibert, Myriam Delaunay, Amélie Lusque, Nadia Boubekeur, Isabelle Rouquette

Lung Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].
Sylvie Lantuejoul, Julien Adam, Nicolas Girard, Mickael Duruisseaux, Audrey Mansuet-Lupo, Isabelle Rouquette

Ann Pathol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis